Sofgen Pharma SAPROCF
13F holders, Q4 2024 (December 31)5holders
2new positions
2sold out
$7.28avg. 13F price*
At the end of Q4 2024, 5 institutions reported holding Sofgen Pharma SA (PROCF) in their 13F filings, unchanged from Q3 2024. 2 opened new positions and 2 sold out. The largest holders were Itau Unibanco Holding S.A. ($1.5M), Geode Capital Management, LLC ($76K) and Activest Wealth Management ($23K).
- Company
- Sofgen Pharma SA
- Filed as
- PROCAPS GROUP SA (Q4 2024)
- CUSIP
- L7756P102
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $1.5M |
| Exits | 2 | $281K |
All 13F filers, Q3 2024 → Q4 2024: 182,401 shares bought and 127,151 shares sold, net +55,250 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Itau Unibanco Holding S.A. | 0.05% | New | 177,974 | $1.5M |
| Geode Capital Management, LLC | 0.00% | Add +15.1% | 33,316 | $76K |
| Activest Wealth Management | 0.01% | No change | 10,000 | $23K |
| Morgan Stanley | 0.00% | No change | 100 | $234 |
| UBS Group AG | 0.00% | New | 49 | $115 |
"% of holder's portfolio" is PROCF's weight in each manager's 13F, not the share of Sofgen Pharma SA the manager owns.